BR9706386A - Antagonistas do receptor de vitronectina, sua preparação e seu us0 - Google Patents
Antagonistas do receptor de vitronectina, sua preparação e seu us0Info
- Publication number
- BR9706386A BR9706386A BR9706386-0A BR9706386A BR9706386A BR 9706386 A BR9706386 A BR 9706386A BR 9706386 A BR9706386 A BR 9706386A BR 9706386 A BR9706386 A BR 9706386A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- receptor antagonists
- vitronectin receptor
- compounds
- vitronectin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"ANTAGONISTAS DO RECEPTOR DE VITRONECTINA, SUA PREPARAçãO E SEU USO". A presente invenção se refere a compostos de fórmula I, A-B-D-E-F-G (I) em que A, B, D, E, F e G têm os significados dados nas reivindicações da patente, à sua preparação e ao seu uso como medicamentos. Os compostos da invenção são usados como antagonistas do receptor da vitronectina e como inibidores da ressorção óssea.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19653645A DE19653645A1 (de) | 1996-12-20 | 1996-12-20 | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9706386A true BR9706386A (pt) | 2003-04-22 |
Family
ID=7815760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9706386-0A BR9706386A (pt) | 1996-12-20 | 1997-12-17 | Antagonistas do receptor de vitronectina, sua preparação e seu us0 |
Country Status (19)
Country | Link |
---|---|
US (1) | US5990145A (pt) |
EP (1) | EP0854145A3 (pt) |
JP (1) | JPH10182617A (pt) |
KR (1) | KR19980064419A (pt) |
CN (1) | CN1200373A (pt) |
AR (1) | AR010369A1 (pt) |
AU (1) | AU729760B2 (pt) |
BR (1) | BR9706386A (pt) |
CA (1) | CA2225267A1 (pt) |
CZ (1) | CZ411297A3 (pt) |
DE (1) | DE19653645A1 (pt) |
HU (1) | HUP9702509A3 (pt) |
ID (1) | ID19245A (pt) |
IL (1) | IL122643A0 (pt) |
NO (1) | NO975975L (pt) |
NZ (1) | NZ329429A (pt) |
PL (1) | PL323968A1 (pt) |
TR (1) | TR199701645A2 (pt) |
ZA (1) | ZA9711315B (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19647380A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
CN1398189A (zh) | 1998-12-23 | 2003-02-19 | G.D.西尔公司 | 用于***形成的放疗与cox-2抑制剂的联合治疗 |
US6545032B1 (en) * | 1999-09-17 | 2003-04-08 | Torrey Pines Institute For Molecular Studies | Synthesis of [3,5,7]-H-imidazo[1,5-a] imidazol-2(3H)-one compounds |
DE10028575A1 (de) | 2000-06-14 | 2002-03-14 | Basf Ag | Integrinliganden |
ES2344546T3 (es) * | 2001-03-19 | 2010-08-31 | Dainippon Sumitomo Pharma Co., Ltd. | Compuesto aliciclico sustituido con arilo y composicion farmaceutica que lo contiene. |
ATE510557T1 (de) | 2001-04-24 | 2011-06-15 | Merck Patent Gmbh | Kombinationstherapie mit antiangiogenen mitteln und tnfalpha |
KR20100054884A (ko) | 2001-10-22 | 2010-05-25 | 더 스크립스 리서치 인스티튜트 | 항체 표적화 화합물 |
HUP0402003A3 (en) | 2001-11-13 | 2005-06-28 | Dimensional Pharm Inc | Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof |
US7205315B2 (en) * | 2003-09-27 | 2007-04-17 | Sanofi-Aventis Deutschland Gmbh | Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
WO2007048127A2 (en) * | 2005-10-20 | 2007-04-26 | The Scripps Research Institute | Fc labeling for immunostaining and immunotargeting |
AR056155A1 (es) * | 2005-10-26 | 2007-09-19 | Bristol Myers Squibb Co | Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica |
WO2007084670A2 (en) | 2006-01-18 | 2007-07-26 | Merck Patent Gmbh | Specific therapy using integrin ligands for treating cancer |
US7553836B2 (en) * | 2006-02-06 | 2009-06-30 | Bristol-Myers Squibb Company | Melanin concentrating hormone receptor-1 antagonists |
ES2399159T3 (es) | 2007-01-18 | 2013-03-26 | Merck Patent Gmbh | Terapia y medicamento específicos usando ligandos de integrinas para el tratamiento del cáncer |
CN101686680B (zh) | 2007-03-09 | 2015-12-09 | 伊沃泰克美国股份有限公司 | 作为p2x7调节剂的双环杂芳基化合物及其用途 |
PE20091928A1 (es) * | 2008-05-29 | 2009-12-31 | Bristol Myers Squibb Co | Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos |
US8518927B2 (en) | 2009-02-10 | 2013-08-27 | The Scripps Research Institute | Chemically programmed vaccination |
CA2763275A1 (en) | 2009-05-25 | 2010-12-02 | Merck Patent Gmbh | Continuous administration of integrin ligands for treating cancer |
MX2016015467A (es) | 2014-05-30 | 2017-03-23 | Pfizer | Derivados de carbonitrilo como moduladores selectivos del receptor de androgenos. |
WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE228115T1 (de) * | 1991-06-28 | 2002-12-15 | Smithkline Beecham Corp | Bizyklische fibrinogenantagonisten |
US5204350A (en) * | 1991-08-09 | 1993-04-20 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
US5217994A (en) * | 1991-08-09 | 1993-06-08 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
AU674553B2 (en) * | 1992-10-14 | 1997-01-02 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU675689B2 (en) * | 1992-12-01 | 1997-02-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
AU689762B2 (en) * | 1992-12-21 | 1998-04-09 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
JPH10501222A (ja) * | 1994-05-27 | 1998-02-03 | メルク エンド カンパニー インコーポレーテッド | 破骨細胞仲介骨吸収を抑制するための化合物 |
MX9700041A (es) * | 1994-06-29 | 1997-04-30 | Smithkline Beecham Corp | Antagonistas de receptor de vitronectina. |
ZA955391B (en) * | 1994-06-29 | 1996-02-09 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
WO1996026190A1 (en) * | 1995-02-22 | 1996-08-29 | Smithkline Beecham Corporation | Integrin receptor antagonists |
DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
SI0910563T1 (en) * | 1995-06-29 | 2003-10-31 | Smithkline Beecham Corporation | Integrin receptor antagonists |
KR19990076878A (ko) * | 1995-12-29 | 1999-10-25 | 스티븐 베네티아너 | 비트로넥틴 수용체 길항제 |
EP0895475A4 (en) * | 1995-12-29 | 2000-08-23 | Smithkline Beecham Corp | VITRONECTIN RECEPTOR ANTAGONISTS |
IL125030A0 (en) * | 1995-12-29 | 1999-01-26 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
PT796855E (pt) * | 1996-03-20 | 2002-07-31 | Hoechst Ag | Inibicao da reabsorcao nos ossos e antagonistas de vitronectina |
DE19629817A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
DE19629816A1 (de) * | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
-
1996
- 1996-12-20 DE DE19653645A patent/DE19653645A1/de not_active Withdrawn
-
1997
- 1997-12-12 EP EP97121931A patent/EP0854145A3/de not_active Withdrawn
- 1997-12-17 BR BR9706386-0A patent/BR9706386A/pt not_active IP Right Cessation
- 1997-12-17 ZA ZA9711315A patent/ZA9711315B/xx unknown
- 1997-12-18 TR TR97/01645A patent/TR199701645A2/xx unknown
- 1997-12-18 NZ NZ329429A patent/NZ329429A/xx unknown
- 1997-12-18 ID IDP973917A patent/ID19245A/id unknown
- 1997-12-18 IL IL12264397A patent/IL122643A0/xx unknown
- 1997-12-18 CZ CZ974112A patent/CZ411297A3/cs unknown
- 1997-12-18 AR ARP970105994A patent/AR010369A1/es unknown
- 1997-12-18 AU AU48464/97A patent/AU729760B2/en not_active Ceased
- 1997-12-19 HU HU9702509A patent/HUP9702509A3/hu unknown
- 1997-12-19 NO NO975975A patent/NO975975L/no not_active Application Discontinuation
- 1997-12-19 CN CN97129789A patent/CN1200373A/zh active Pending
- 1997-12-19 CA CA002225267A patent/CA2225267A1/en not_active Abandoned
- 1997-12-20 KR KR1019970071175A patent/KR19980064419A/ko not_active Application Discontinuation
- 1997-12-20 PL PL97323968A patent/PL323968A1/xx unknown
- 1997-12-22 JP JP9365528A patent/JPH10182617A/ja active Pending
- 1997-12-22 US US08/995,522 patent/US5990145A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH10182617A (ja) | 1998-07-07 |
EP0854145A2 (de) | 1998-07-22 |
HUP9702509A2 (hu) | 1999-06-28 |
HUP9702509A3 (en) | 2001-04-28 |
CA2225267A1 (en) | 1998-06-20 |
NZ329429A (en) | 1999-05-28 |
HU9702509D0 (en) | 1998-03-02 |
CZ411297A3 (cs) | 1998-07-15 |
DE19653645A1 (de) | 1998-06-25 |
AR010369A1 (es) | 2000-06-07 |
AU4846497A (en) | 1998-06-25 |
ZA9711315B (en) | 1998-06-22 |
PL323968A1 (en) | 1998-06-22 |
NO975975D0 (no) | 1997-12-19 |
NO975975L (no) | 1998-06-22 |
EP0854145A3 (de) | 2000-03-22 |
US5990145A (en) | 1999-11-23 |
ID19245A (id) | 1998-06-28 |
KR19980064419A (ko) | 1998-10-07 |
IL122643A0 (en) | 1998-08-16 |
MX9710389A (es) | 1998-08-30 |
TR199701645A3 (tr) | 1998-07-21 |
CN1200373A (zh) | 1998-12-02 |
TR199701645A2 (xx) | 1998-07-21 |
AU729760B2 (en) | 2001-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9706386A (pt) | Antagonistas do receptor de vitronectina, sua preparação e seu us0 | |
BRPI9605663B8 (pt) | Bis (resorcinil) triazinas. | |
SE8804629D0 (sv) | New therapeutically active compounds | |
YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
AR066982A2 (es) | Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos | |
SE9504661D0 (sv) | New compounds | |
BR0107888A (pt) | Pirrolidinas 1,3-dissubstituidas como antagonistas de alfa-2adrenorreceptor | |
ES2102475T3 (es) | Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
BR0009702A (pt) | Compostos ou seus sais, uso de compostos ou sais, e, formulações farmacêuticas | |
BR9611175B1 (pt) | compostos e composiÇÕes farmacÊuticas. | |
BR0009703A (pt) | Compostos ou sais, ou composições uso dos mesmos, e, formulações farmacêuticas | |
SE9904505D0 (sv) | Novel compounds | |
ATE241990T1 (de) | 3-beta-hydroxylierte natürliche steroidderivate enthaltende arzneimittelzusammensetzungen und ihre verwendung | |
ES2157993T3 (es) | Benzoilguanidinas, su preparacion y su uso en medicamentos. | |
BR9706387A (pt) | Derivados de purina substituìdos, processos para a sua preparação, seu emprego e composições contendo os mesmos | |
CA2211270A1 (en) | Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists | |
AR012294A1 (es) | Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento. | |
DE3783356D1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
BR9812492A (pt) | Composto, uso do mesmo, formulação farmacêutica, e, processos para o tratamento de uma doença cardiovascular, para o tratamento de uma vasoconstrição, e para a preparação de compostos | |
BR0012610A (pt) | Novo derivado de difenilpiperidina | |
BR9702074A (pt) | Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações | |
IT1302264B1 (it) | Derivati a struttura n-acil vanillinamidica in grado di attivare irecettori periferici dei cannabinoidi | |
DE69525649D1 (de) | Lamotrigin haltiges arzneimittel | |
BR0309896A (pt) | Compostos, uso em um composto, composição farmacêutica, composição cosmética, uso cosmético de uma composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A,7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1833 DE 21/02/2006. |